CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes EVP & General Manager US gave up 3,675 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 1,021 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Manager, Europe gave up 202 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Head of Tech. Operations gave up 202 shares (to pay taxes)
- 4 Planned sale EVP & Chief Medical Officer sold 7,365 shares at $65.51 ($482,481)
- 4 Planned sale EVP, GMAPPS sold 657 shares at $65.00 ($42,705)
- 4 Grant or award Director acquired 1,112 shares (grant or award)
- 4 Grant or award Director acquired 412 shares (grant or award)
- 4 Grant or award Director acquired 423 shares (grant or award)
- 4 Planned sale Principal Accounting Officer sold 1,277 shares at an average $61.55 ($78,594)
- 4 Grant or award EVP & General Counsel acquired 26,524 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,020 shares (grant or award)
- 4 Grant or award Director acquired 389 shares (grant or award)
- 4 Grant or award Director acquired 379 shares (grant or award)
- 4 Open-market sale EVP, Human Resources sold 8,449 shares at $65.13 ($550,283)
Page 14 of 82 · 1,628 filings